For: | Farhat MH, Shamseddine AI, Tawil AN, Berjawi G, Sidani C, Shamseddeen W, Barada KA. Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index. World J Gastroenterol 2008; 14(20): 3224-3230 [PMID: 18506930 DOI: 10.3748/wjg.14.3224] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i20/3224.htm |
Number | Citing Articles |
1 |
W. F. Shen, W. Zhong, Q. Liu, C. J. Sui, Y. Q. Huang, J. M. Yang. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study. World Journal of Surgery 2011; 35(9): 2083 doi: 10.1007/s00268-011-1171-y
|
2 |
Wei-Wen Chang, Ping-Kun Hsiao, Lei Qin, Chia-Lun Chang, Jyh-Ming Chow, Szu-Yuan Wu. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric. Radiotherapy and Oncology 2018; 129(2): 284 doi: 10.1016/j.radonc.2018.09.010
|
3 |
Wayne A. Warner, Wesley Ramcharan, Dave Harnanan, Srikanth Umakanthan, Ravi Maharaj. A case of distal extrahepatic cholangiocarcinoma with two positive resection margins. Oncology Letters 2016; 12(5): 4075 doi: 10.3892/ol.2016.5174
|
4 |
Chun‐Fu Ting, Wen‐Hsin Huang, Chun‐Lung Feng, Cheng‐Ju Yu, Cheng‐Yuan Peng, Wen‐Pang Su, Hsueh‐Chou Lai, Ken‐Sheng Cheng, Po‐Heng Chuang, Jung‐Ta Kao. Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma. Advances in Digestive Medicine 2016; 3(1): 11 doi: 10.1016/j.aidm.2014.12.004
|
5 |
Neenu Jojan, Geetha Sukumaran. Assessment of Microvascular Density in Cholangiocarcinoma. Journal of Evidence Based Medicine and Healthcare 2021; 8(01): 6 doi: 10.18410/jebmh/2021/2
|
6 |
Jinwoo Kang, Sang Hyub Lee, Jun Hyuk Son, Jae Woo Lee, Young Hoon Choi, Jin Ho Choi, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Gianfranco D. Alpini. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients. PLOS ONE 2018; 13(4): e0195118 doi: 10.1371/journal.pone.0195118
|
7 |
Shinya Takaoka, Tsuyoshi Hamada, Naminatsu Takahara, Rintaro Fukuda, Ryunosuke Hakuta, Kazunaga Ishigaki, Sachiko Kanai, Kohei Kurihara, Hiroki Matsui, Nobuaki Michihata, Hiroto Nishio, Kensaku Noguchi, Hiroki Oyama, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Yukari Suzuki, Shuichi Tange, Kiyohide Fushimi, Yousuke Nakai, Hideo Yasunaga, Mitsuhiro Fujishiro. Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation. Journal of Gastroenterology 2024; 59(8): 732 doi: 10.1007/s00535-024-02124-9
|
8 |
Mario Fernández-Ruiz, Juan-Manuel Guerra-Vales, Francisco Colina-Ruizdelgado. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2009; 15(42): 5279-5286 doi: 10.3748/wjg.15.5279
|
9 |
George N Zografos, Athanasios Farfaras, Flora Zagouri, Dimosthenis Chrysikos, Kostas Karaliotas. Cholangiocarcinoma: principles and current trends. Hepatobiliary & Pancreatic Diseases International 2011; 10(1): 10 doi: 10.1016/S1499-3872(11)60001-5
|
10 |
Y.G. Li, N. Zhang. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma. Digestive and Liver Disease 2009; 41(8): 605 doi: 10.1016/j.dld.2008.11.010
|
11 |
Kota Sahara, Diamantis I. Tsilimigras, Junya Toyoda, Kentaro Miyake, Cecilia G. Ethun, Shishir K. Maithel, Daniel E. Abbott, George A. Poultsides, Ioannis Hatzaras, Ryan C. Fields, Matthew Weiss, Charles Scoggins, Chelsea A. Isom, Kamran Idrees, Perry Shen, Yasuhiro Yabushita, Ryusei Matsuyama, Itaru Endo, Timothy M. Pawlik. Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma. Annals of Surgical Oncology 2021; 28(8): 4205 doi: 10.1245/s10434-021-09811-4
|
12 |
Alireza Rezaee, Rathan M. Subramaniam, Markus Raderer, Werner Langsteger, Mohsen Beheshti. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. 2018; : 127 doi: 10.1016/B978-0-323-48567-8.00007-9
|
13 |
Vanessa da Costa Miranda, Maria Ignez Braghiroli, Luiza Dib Batista Bugiato Faria, Sheila Aparecida Coelho Siqueira, Jorge Sabbaga, Paulo M. Hoff, Rachel P. Riechelmann. ERCC1 in Advanced Biliary Tract Cancer Patients Treated with Chemotherapy: Prognostic and Predictive Roles. Journal of Gastrointestinal Cancer 2014; 45(1): 80 doi: 10.1007/s12029-013-9568-5
|
14 |
Yu. I. Patyutko, A. N. Polyakov, D. V. Podluzhnyi, A. Yu. Syskova, I. V. Sagaidak, A. G. Kotel'nikov, O. N. Sergeeva, I. A. Pokataev. Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment. Khirurgiya. Zhurnal im. N.I. Pirogova 2018; (12): 30 doi: 10.17116/hirurgia201812130
|
15 |
Tomotaka Kato, Katsuya Okada, Yasutaka Baba, Masanori Yasuda, Yuhei Ohshima, Kenichiro Takase, Yuichiro Watanabe, Yukihiro Watanabe, Masayasu Aikawa, Kojun Okamoto, Isamu Koyama. Preoperative prognostic stratification and prediction of long-term outcomes after pancreatoduodenectomy for distal cholangiocarcinoma. European Journal of Surgical Oncology 2024; 50(12): 108691 doi: 10.1016/j.ejso.2024.108691
|
16 |
Stéphane Gérard, D. Bréchemier, A. Lefort, S. Lozano, G. Abellan Van Kan, T. Filleron, L. Mourey, C. Bernard-Marty, M.E. Rougé-Bugat, V. Soler, B. Vellas, M. Cesari, Y. Rolland, L. Balardy. Body composition and anti-neoplastic treatment in adult and older subjects - A systematic review. The Journal of nutrition, health and aging 2016; 20(8): 878 doi: 10.1007/s12603-015-0653-2
|